# Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

> **NCT02528110** · PHASE2 · COMPLETED · sponsor: **Wuhan University** · enrollment: 100 (actual)

## Conditions studied

- Malignant Neoplasm of Stomach

## Interventions

- **PROCEDURE:** Hyperthermic intraperitoneal chemotherapy (HIPEC)
- **PROCEDURE:** D2 radical gastrectomy
- **OTHER:** SOX postoperative chemotherapy
- **OTHER:** XELOX postoperative chemotherapy

## Key facts

- **NCT ID:** NCT02528110
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-03-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02528110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02528110, "Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02528110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*